The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted a proof-of-concept study showing how similar compounds can precisely target ...

Research is constantly evolving in the world of cognitive health, including for neurological diseases for which there are currently no cures or guaranteed preventive methods. In regards to the most ...

Rutgers neuroscientist Peng Jiang was visiting his hometown of Qianshan, a city in China's Anhui province, when a neighbor came to his parents' house with a story that would stay with him.

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease and other cognitive decline, and it goes a long way to explaining why there ...

Recent findings, reported on November 15, 2025, have cast a shadow over one of the most anticipated breakthroughs in Alzheimer’s treatment. The results suggest that the much-touted amyloid ...

With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...

After covering the Alzheimer’s space through every high and low, BioSpace’s Annalee Armstrong welcomes back Roche for the 2026 Alzheimer’s Renaissance.